Alexander Mader
Dipl.-Ing. Dr. Alexander Mader
Status aktuell nicht an der BOKU tätig
Projekte
Es wurden 0 Projekte gefunden.
Publikationen
Wissentransfer in die Gesellschaft
Medienbeiträge
Vorträge
Jahr: 2016 - AllergoOncology: generation of a canine anti-EGFR anticancer IgE
Autoren: Fazekas, J; Singer, J; Matz, M; Mader, A; Spillner, E; Kunert, R; Jensen-Jarolim, E
Veranstaltung: Meeting of the European Academy of Allergy and Clinical Immunology 2016
Jahr: 2015 - Identification of bottlenecks in antibody expression using targeted gene integration
Autoren: Mayrhofer, P; Mader, A; Kratzer, B; Reinhart, D; Steinfellner, W; Sommeregger, W; Kunert, R
Veranstaltung: 24th ESACT 2015 - Cells, Culture, Patients, Products
Jahr: 2015 - Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions
Autoren: Wallner, J; Lhota, G; Jeschek, D; Mader, A; Vorauer-Uhl, K.
Veranstaltung: BIOMATSEN, International Congress on Biomaterials & Biosensors
Jahr: 2015 - Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions
Autoren: Wallner, J; Lhota, G; Jeschek, D; Mader, A; Vorauer-Uhl, K.
Veranstaltung: 9. Deutsches BioSensor Symposium
Jahr: 2014 - RMCE reference sites – A valuable tool for comparing antibody expression capabilities in CHO cells
Autoren: Mayrhofer, P; Mader, A; Kunert, R
Veranstaltung: 16th European Congress on Biotechnology 2014
Jahr: 2014 - Can225IgG, the first 'caninised' antibody against EGFR is highly effective in mediating tumor cell growth inhibition and phagocytosis in vitro
Autoren: Fazekas, J; Singer, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Willmann, M; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E
Veranstaltung: European-Academy-of-Allergy-and-Clinical-Immunology Congress 2014
Jahr: 2014 - Versatile RMCE Integration of Different Antibody Variants into Predictable Reference Sites in CHO Cells
Autoren: Mayrhofer, P; Mader, A; Kunert, R
Veranstaltung: PEGS - Protein and Antibody Engineering Summit 2014
Jahr: 2013 - Passive anti-EGFR immunotherapy in canine cancer patients - a comparative medicine study
Autoren: Fazekas, J; Singer, J; Wang, W; Weichselbaumer, M; Matz, M; Mader, A; Steinfellner, W; Meitz, S; Mechtcheriakova, D; Sobanov, Y; Stockner, T; Spillner, E; Kunert, R; Jensen-Jarolim, E
Veranstaltung: World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization
Jahr: 2013 - IgG to IgM class switch: Modification of protein properties by antibody engineering
Autoren: Mader, A; Chromikova, V; Kunert, R
Veranstaltung: 2nd Workshop: The new ParadIgM - IgM from bench to clinic
Jahr: 2012 - Human recombinant IgMs: a challenging molecule in mammalian cell expression
Autoren: Mader, A; Kunert, R
Veranstaltung: 15th European Congress on Biotechnology ECB15 2012 - Biocrossroads
Jahr: 2011 - Screening and quantification of human IgMs using BioLayer interferometry
Autoren: Alexander Mader Renate Kunert
Veranstaltung: The new ParadIgM 2011 - IgM from bench to clinic
Jahr: 2011 - Recombinant human IgMs: Purification, characterization and modification
Autoren: Renate Kunert
Veranstaltung: The new ParadIgM 2011 - IgM from bench to clinic
Jahr: 2011 - Anti-idiotypic antibody Ab2/3H6 mimicking gp41: a potential HIV-1 vaccine?
Autoren: Renate Kunert Alexander Mader
Veranstaltung: 22nd meeting of the European Society for Animal Cell Technology ESACT 2011
Jahr: 2010 - Humanization variants of an anti-idiotypic antibody
Autoren: Renate Kunert, Alexander Mader, Hermann Katinger
Veranstaltung: Human Antibodies and Hybridomas 2010
Jahr: 2009 - Approaches for humanization of an anti-idiotypic murine monoclonal antibody
Autoren: Alexander Mader, Hermann Katinger, Renate Kunert
Veranstaltung: 21st Meeting of the European Society for Animal Cell Technology ESACT 2009